From: Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies
No. of marker+Â tumor stromal vessels/TMA core
0
1–5
6–10
>10
Mean # vessels/TMA core (range)
Total number of evaluable cores
CD34+Â tumor vessels
9
36
52
89
11 (0–45)
186
VEGFR2+Â tumor vessels
42
90
29
8
3.4 (0–20)
169